Search Site close Close
News

Clinical Study Seeks Participants with Lung Disease

Published Date:

Idiopathic pulmonary fibrosis (IPF) is a type of lung disease that results in scarring (fibrosis) of the lungs for an unknown reason. Over time, the scarring gets worse and it becomes harder to take deep breaths. The lungs become unable to take in enough oxygen.

Dr. Rajagopal Sreedhar is recruiting participants for a clinical trial to see if pulmonary rehabilitation treatments improve the quality of life for patients with IPF. The study will compare standard of care treatment to exercise and education. The goal is test how well the combination of exercise and medication benefits the patient. All study-related visits and tests will be provided at no cost to the participant. Participants may also receive a stipend to cover travel and other related expenses.

To qualify, participants must:

  • Be 40 years of age or older
  • Have been diagnosed with IPF
  • Be currently taking the medication Ofev® (150 mg twice a day) and have taken it at a stable dose for up to 30 months

To learn more about this study, contact Abigail House, RN, at 217-545-7526.

More from SIU News

Kevin Hascup

Hascup Lab, SIUC collaboration to explore new path for Alzheimer’s therapy

A collaboration between neuroscience and engineering will explore a novel approach in reducing formation of plaques commonly found in those with Alzheimer’s. Kevin Hascup, PhD, of the Smith Alzheimer
Alzheimers

Providing hope, quality of life for those with Alzheimer’s

Art Express is one of many programs at the Smith Alzheimer’s Center at SIU Medicine designed to help those with dementia and their caregivers improve their quality of life.
Dr. Chris McDowell

Chris McDowell named Executive Associate Dean of SIU Medicine

Dr. Chris McDowell has been named the new Executive Associate Dean of SIU School of Medicine. He is an alumnus of the school (Class of 2005), chair of Emergency Medicine, an associate professor and the medical director for the Memorial Learning Center.